List of Excipients in API BUPIVACAINE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BUPIVACAINE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Henry Schein Inc | MARCAINE | bupivacaine hydrochloride | 0404-9907 | HYDROCHLORIC ACID | |
| Henry Schein Inc | MARCAINE | bupivacaine hydrochloride | 0404-9907 | SODIUM CHLORIDE | |
| Henry Schein Inc | MARCAINE | bupivacaine hydrochloride | 0404-9907 | SODIUM HYDROXIDE | |
| Henry Schein Inc | MARCAINE | bupivacaine hydrochloride | 0404-9907 | WATER | |
| Henry Schein Inc | SENSORCAINE | bupivacaine hydrochloride | 0404-9947 | HYDROCHLORIC ACID | |
| Henry Schein Inc | SENSORCAINE | bupivacaine hydrochloride | 0404-9947 | METHYLPARABEN | |
| Henry Schein Inc | SENSORCAINE | bupivacaine hydrochloride | 0404-9947 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BUPIVACAINE HYDROCHLORIDE
Detailed excipient profiles for BUPIVACAINE HYDROCHLORIDE
Excipient focus: ANHYDROUS DEXTROSE
BUPIVACAINE HYDROCHLORIDE drug variants containing ANHYDROUS DEXTROSE
BUPIVACAINE HYDROCHLORIDE drug variants not containing ANHYDROUS DEXTROSE
Excipient focus: ASCORBIC ACID
BUPIVACAINE HYDROCHLORIDE drug variants containing ASCORBIC ACID
BUPIVACAINE HYDROCHLORIDE drug variants not containing ASCORBIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
BUPIVACAINE HYDROCHLORIDE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| REMEDYREPACK INC | bupivacaine hydrochloride and epinephrine bitartrate | 70518-2657 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE HYDROCHLORIDE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: DEXTROSE
BUPIVACAINE HYDROCHLORIDE drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Brookfield Pharmaceuticals LLC | bupivacaine hydrochloride | 71351-022 |
| Huons Co Ltd | bupivacaine hydrochloride | 73293-0002 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE HYDROCHLORIDE drug variants not containing DEXTROSE
Excipient focus: EDETATE CALCIUM DISODIUM
BUPIVACAINE HYDROCHLORIDE drug variants containing EDETATE CALCIUM DISODIUM
BUPIVACAINE HYDROCHLORIDE drug variants not containing EDETATE CALCIUM DISODIUM
Excipient focus: HYDROCHLORIC ACID
BUPIVACAINE HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID
BUPIVACAINE HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
| Carestream Health Inc | bupivacaine hydrochloride and epinephrine bitartrate | 31382-557 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
BUPIVACAINE HYDROCHLORIDE drug variants containing METHYLPARABEN
BUPIVACAINE HYDROCHLORIDE drug variants not containing METHYLPARABEN
Excipient focus: MONOTHIOGLYCEROL
BUPIVACAINE HYDROCHLORIDE drug variants containing MONOTHIOGLYCEROL
BUPIVACAINE HYDROCHLORIDE drug variants not containing MONOTHIOGLYCEROL
Excipient focus: NITROGEN
BUPIVACAINE HYDROCHLORIDE drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Brookfield Pharmaceuticals LLC | bupivacaine hydrochloride | 71351-022 |
| Huons Co Ltd | bupivacaine hydrochloride | 73293-0002 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE HYDROCHLORIDE drug variants not containing NITROGEN
Excipient focus: SODIUM CHLORIDE
BUPIVACAINE HYDROCHLORIDE drug variants containing SODIUM CHLORIDE
BUPIVACAINE HYDROCHLORIDE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
BUPIVACAINE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
BUPIVACAINE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
| Carestream Health Inc | bupivacaine hydrochloride and epinephrine bitartrate | 31382-557 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LACTATE
BUPIVACAINE HYDROCHLORIDE drug variants containing SODIUM LACTATE
BUPIVACAINE HYDROCHLORIDE drug variants not containing SODIUM LACTATE
Excipient focus: SODIUM METABISULFITE
BUPIVACAINE HYDROCHLORIDE drug variants containing SODIUM METABISULFITE
BUPIVACAINE HYDROCHLORIDE drug variants not containing SODIUM METABISULFITE
Excipient focus: WATER
BUPIVACAINE HYDROCHLORIDE drug variants containing WATER
BUPIVACAINE HYDROCHLORIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
